Roderick Hafner
Director/Board Member bij Circassia Pharma Ltd.
Profiel
Roderick Peter Hafner is on the board of Circassia Pharma Ltd.
In the past he was Director, Senior VP-Research & Development at Niox Group Plc and Director, Senior VP-Research & Development at Circassia Ltd.
(a subsidiary of Niox Group Plc), Principal at Procter & Gamble Co., Head-Project Management at Provalis Plc and Head-Project Management at Cortecs International Ltd.
(a subsidiary of Provalis Plc), Principal at Wyeth Corp., Vice President-Development at Powderject Pharmaceuticals Plc and Principal at Optinose AS.
Dr. Hafner received an undergraduate degree from The University of Edinburgh and a doctorate from the University of Cambridge.
Actieve functies van Roderick Hafner
Bedrijven | Functie | Begin |
---|---|---|
Circassia Pharma Ltd.
Circassia Pharma Ltd. Medical/Nursing ServicesHealth Services Circassia Pharma Ltd. is a biopharmaceutical company, which engages as a subsidiary of Circassia Pharmaceuticals plc. It focuses on the research and development of respiratory disease and allergy products. The company was founded on October 26, 2007 and is headquartered in Oxford, the United Kingdom. | Director/Board Member | 29-10-2007 |
Eerdere bekende functies van Roderick Hafner
Bedrijven | Functie | Einde |
---|---|---|
NIOX GROUP PLC | Chief Tech/Sci/R&D Officer | 01-04-2020 |
Circassia Ltd.
Circassia Ltd. Pharmaceuticals: OtherHealth Technology Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom. | Chief Tech/Sci/R&D Officer | - |
Powderject Pharmaceuticals Plc
Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Corporate Officer/Principal | - |
Cortecs International Ltd. | Corporate Officer/Principal | - |
Adiga Life Sciences, Inc.
Adiga Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Adiga Life Sciences, Inc. operates as a healthcare company that conducts medical researches. It develops technologies to control immune function in allergic and auto immune diseases. The company was founded on November 25, 2008 and is headquartered in Hamilton, Canada. | Director/Board Member | - |
Opleiding van Roderick Hafner
University of Cambridge | Doctorate Degree |
The University of Edinburgh | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
PROCTER & GAMBLE COMPANY | Consumer Non-Durables |
NIOX GROUP PLC | Health Services |
Bedrijven in privébezit | 8 |
---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Provalis Plc | Health Technology |
Circassia Ltd.
Circassia Ltd. Pharmaceuticals: OtherHealth Technology Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Powderject Pharmaceuticals Plc
Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Health Technology |
Optinose AS
Optinose AS Medical SpecialtiesHealth Technology OptiNose AS develops, produces, administers, commercializes, and distributes exhalation drug delivery systems. It offers single and multi-use intranasal delivery devices for liquid and powder formulations. The company was founded on September 9, 2007 and is headquartered in Oslo, Norway. | Health Technology |
Cortecs International Ltd. | Miscellaneous |
Adiga Life Sciences, Inc.
Adiga Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Adiga Life Sciences, Inc. operates as a healthcare company that conducts medical researches. It develops technologies to control immune function in allergic and auto immune diseases. The company was founded on November 25, 2008 and is headquartered in Hamilton, Canada. | Health Technology |
Circassia Pharma Ltd.
Circassia Pharma Ltd. Medical/Nursing ServicesHealth Services Circassia Pharma Ltd. is a biopharmaceutical company, which engages as a subsidiary of Circassia Pharmaceuticals plc. It focuses on the research and development of respiratory disease and allergy products. The company was founded on October 26, 2007 and is headquartered in Oxford, the United Kingdom. | Health Services |